Scienture (NASDAQ:SCNX) Shares Down 2.7% – What’s Next?

Scienture Holdings, Inc. (NASDAQ:SCNX) dropped 2.7% on Tuesday . The stock traded as low as $0.83 and last traded at $0.87. Approximately 126,298 shares traded hands during trading, a decline of 71% from the average daily volume of 440,569 shares. The stock had previously closed at $0.89.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut Scienture from a “hold” rating to a “sell” rating in a research report on Sunday, August 17th.

Scienture Stock Down 2.7%

The firm has a fifty day simple moving average of $1.58 and a 200 day simple moving average of $1.35. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.02.

Scienture (NASDAQ:SCNX) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($0.48) earnings per share for the quarter. Scienture had a negative net margin of 10,364.22% and a negative return on equity of 24.47%.

Institutional Investors Weigh In On Scienture

An institutional investor recently bought a new position in Scienture stock. Millennium Management LLC bought a new stake in Scienture Holdings, Inc. (NASDAQ:SCNX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 33,987 shares of the company’s stock, valued at approximately $206,000. Millennium Management LLC owned 0.39% of Scienture at the end of the most recent quarter. 5.68% of the stock is currently owned by institutional investors.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.